oral semaglutide news diabetes drug fights obesity in mice: A game-changer for human treatment? Big news in obesity medicine

If your weight loss is on track and side effects manageable, your prescriber may keep you at 0.5 mg

The trial, which began in October 2018, was originally designed to test the hypothesis that semaglutide could protect nondiabetic patients with metabolic syndrome, a condition characterized by excess body fat and insulin resistance, from cardiovascular events

Patients nationwide can begin treatment immediately through a simple online consultation with a licensed physician

These chronobiological properties make Pinealon a valuable research tool for investigating circadian biology, developing strategies for circadian rhythm disorders, and understanding the complex relationships between biological timing, aging, and health outcomes

Front Nutr 11:1325894

This advanced Japanese serum helps brighten, repair, and deeply hydrate the skin, promoting a smoother, more radiant and even-toned complexion